Wall Street Cuts Ratings on Teradyne, DoubleVerify and More
Five notable stock downgrades hit Friday as Baird, HSBC, Canaccord, and JP Morgan all pulled back their bullish calls.
Five companies absorbed significant rating cuts from major Wall Street firms on Friday, signaling growing caution across technology, steel, and healthcare analytics sectors. Baird led the session's downgrade activity by stripping Teradyne Inc of its Outperform rating, moving the semiconductor test equipment maker to Neutral. The shift marks a meaningful reversal for a firm that had previously backed the stock's upside potential.
JP Morgan delivered two separate cuts in a single session, downgrading digital advertising verification company DoubleVerify Holdings Inc from Overweight to Neutral and pushing mechanical contractor Limbach Holdings Inc one step further — from Neutral all the way down to Underweight. A move to Underweight is particularly pointed, as it signals the analyst expects the stock to trail its peers or the broader market.
Read more Dow Futures Rise as Nvidia Earnings Loom Amid New Canada Tariffs →
Meanwhile, HSBC downgraded Latin American steelmaker Ternium SA from Buy to Hold, while Canaccord Genuity trimmed its view on health data analytics firm Health Catalyst Inc from Buy to Hold as well. Taken together, the five downgrades span industrial, technology, and healthcare sectors, suggesting broad-based reassessment rather than a single-theme pullback.
For investors, a cluster of high-profile downgrades on a single trading day can carry added weight — multiple independent firms reaching similar conclusions simultaneously may reflect shared concerns about earnings visibility, valuation, or macroeconomic headwinds affecting multiple corners of the market. None of the firms disclosed specific price-target changes in the initial coverage, leaving traders to parse the directional signal on its own.
Continue reading at Sahm.
